最近在CAR-T细胞治疗方面的进展和当前的挑战.
1EnviroCORE, Department of Applied Science, South East Technological University, SETU Carlow, Kilkenny Road, Carlow, R93V960, Ireland.
Biotechnology letters
|December 27, 2023
概括
化学抗原受体-T (CAR-T) 细胞疗法为某些血液癌症提供了高响应率,但面临着挑战. 提高安全性,有效性和可访问性是其未来实施的关键.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 免疫疗法,特别是化学抗原受体-T (CAR-T) 细胞疗法,代表了癌症治疗的重大进展.
- 卡特-T疗法涉及修改患者自己的T细胞以向和消除癌细胞,革命性地改变了某些恶性瘤的治疗方法.
研究的目的:
- 审查CAR-T细胞疗法的最新进展.
- 检查美国 (美国) 和欧盟 (欧盟) 的当前挑战和监管格局.
- 为导航进入全球市场的研究人员和制造商提供关键的见解.
主要方法:
- 关于CAR-T细胞疗法的最新进展的文献综述.
- 分析美国和欧盟的监管框架.
- 综合有关临床试验进展和结果的数据.
主要成果:
- 在血液性恶性瘤中,CAR-T疗法显示出高响应率和长期缓解的潜力.
- 仍然存在重大挑战,包括高成本,不良反应和对固体瘤的有效性有限.
- 全球有超过1231个CAR-T细胞治疗临床试验正在进行中,这表明发展迅速.
结论:
- 在癌症治疗方面,CAR-T细胞疗法具有巨大的前景.
- 提高安全性,有效性和可访问性对于广泛的临床实施至关重要.
- 导航监管途径对于全球可访问性至关重要.
相关概念视频
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K